Trial intelligence / Profile preview

Three-dose betamethasone regimen versus standard two-dose regimen in twin pregnancies with threatened preterm birth

2016-003603-61Phase 4Completed

Start: Feb 2017
Modality: Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries: 1

Overview

Phase 4 trial of betamethasone in preterm birth, respiratory distress syndrome (RDS) and Pregnancy-related complication (2 arms). Primary endpoint: Proportion of respiratory distress syndrome in the two groups. Started Feb 2017; status: completed.

Drugs

betamethasone

Conditions

preterm birthrespiratory distress syndrome (RDS)Pregnancy-related complication

Beyond the preview

Go deeper on 2016-003603-61.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2016-003603-61.